Skip to main contentSkip to navigationSkip to search

Transparency reporting

Below is information containing Camurus' disclosures of transfers of values, which is made available in accordance with applicable laws, regulations and/or industry code. In addition, more detailed information regarding Camurus' grants and donations to healthcare and patient organizations, and Investigator Sponsored Studies are disclosed below. 

corporate


Grants and donations to healthcare and patient organizations

See below for information on grants and donations provided by Camurus AB since January 2022, including requests for such support which have been received by the company’s subsidiaries. 

The disclosure includes grants and donations given to healthcare organizations (eg. healthcare, medical or scientific association or society, hospital, clinic, foundation, university or other teaching institution), or similar (e.g. research institutions in the field of medicine), and patient organizations and similar.

During 2025, the list below will be updated regularly, as new projects have been granted support by Camurus and are agreed with the recipient organization. 

Previous years: 

Grants and donations disclosure 2024 (pdf)
Grants disclosure 2023 (pdf)
Grants disclosure 2022 (pdf)

Grants disclosures and donations 2025
 Approval date Organization (recipient)  Country/ region (recipient) 

Patient organization
(Yes/No)

Grant project description  Purpose/category Amount 
3 September  The Pituitary Society  US No “Pituitary Advances In The Spotlight: 2025 Rapid Fire Webinar”  Educational/Event  10,000 USD 
28 August Aidshilfe Niedersachsen Landesverband e.v.  Germany Yes “Survey and outreach health work in the drug scene in Celle”  Research/Patient Support  5,157 EUR 
29 July Health without Barriers  France  No “E-learning on the prescription of OST in French and English”  Educational  16,000 EUR 
29 July Fallen Angels Dance Theatre  UK No “Fallen Angels Dance  Theatre – Perspectives 2025”  Patient Support  8,000 GBP 
- National Domestic Violence Hotline United States No

-

Camurus' Value Award donation Q2 2025 230 USD
- Northumbria Blood Bikes UK No

-

Camurus' Value Award donation Q2 2025 200 EUR
30 June Red Rose Recovery Lancashire  UK Yes

“Drink and 

Drug News annual conference” 
Educational/Event  8,739.70 GBP 
17 June ENETS / European Neuroendocrine Tumor Society e.V.  Germany No “NextGEN ENETS Scientific Workshop 2025” 

Educational/Event 

10,000 EUR 
10 June Pituitary Research and Education Foundation (PREF)  Italy No “Multistep project leading to the global establishment of Pituitary Tumors Centers of Excellence (PTCOE)” 

Research 

10,000 EUR 
3 June Aidshilfe Niedersachsen Landesverband e.v. Germany Yes “‘Health promotion in custody’ Symposium”

Educational/Event 

2,500 EUR
3 June ENETS / European Neuroendocrine Tumor Society e.V. Germany No “ENETS E-Learning Programme 2025”

Educational/Event 

5,000 EUR
22 April  FOSUMOS - Forum Suchtmedizin Ostschweiz  Switzerland No “Update Sucht Interdisziplinär 2025” 

Educational/Event 

2,000 CHF 
- Mensajeros de la Paz Association  Spain No

-

Camurus' Value Award donation Q1 2025

200 EUR 
- Royal National Lifeboat Institution  UK No

-

Camurus' Value Award donation Q1 2025 

200 EUR 
10 April The General Hospital Corporation dba The Massachusetts General Hospital (MGH)  US No

“MGH Neuroendocrine Unit Physicians’ Pituitary Information Service” 

Educational 

5,000 USD 
28 March Make Time Count Today  UK No

“Assessing impact of technology to support Prison Leavers, especially those continuing a drug treatment programme” 

Patient Support 

85,230 GBP
- Hjärnfonden  Sweden  No

-

Camurus' Value Award donation Q4 2024   200 EUR
14 March Dress for Success NSW & ACT Australia No Donation for International Women’s Day Donation 1,020 AUD
25 February Excel Continuing Education  US No

“Acromegaly: An Interactive Discussion with 3 Physician Experts” 

Educational/Event  15,000 USD 
- German Maritime Search and Rescue Service  Germany  No

-

Camurus' Value Award donation Q4 2024  200 EUR
12 February Addiction Family Support (AFS)  UK Yes

“Supporting people bereaved  

due to a loved one’s harmful use of alcohol, drugs or gambling” 
Patient Support  15,000 GBP 
11 February  PCM Healthcare Limited  UK No

“IOTOD 2025  

spring/summer and autumn/winter IME webinars” 
Educational/Event  48,000 EUR 

Investigator Sponsored Studies (ISS)

Camurus has several Investigator Sponsored Studies (ISS) – research projects run by external researchers with support from Camurus ongoing, which aims to strengthen the  scientific evidence base. Camurus assists in these studies with financial support and/or with product, but is not involved in the design, execution, or interpretation of the results.

Investigator Sponsored Study (ISS) disclosure
ONGOING
Approval date/ contract signingOrganization (recipient) Country (recipient) Title of ISS Amount 
16 September 2024University of Dundee UKLong-acting Buprenorphine and influence on non-fatal overdose in Tayside 168,880 GBP 
 23 June 2023University of Bordeaux France OBAP-A prospective observational study in naturalistic settings to describe Buvidal introduction in France: change in severity of addiction and health related quality of life over a period of 3 months 312,928.80 EUR
 13 December 2023LVR University Hospital Essen, University of Duisburg-Essen Germany Substitution im Alter - Substitution treatment in the elderly – Needs, fears and expectancies of an age-based treatment 12,000 EUR
FINISHED

Approval date/ contract signingOrganization (recipient) Country (recipient) Title of ISS Amount 
11 January 2023Medical University Centre Hamburg-Eppendorf (UKE)Germany Evaluation of treatment needs among opioid dependent drug users currently not in opioid substitution treatment83,900 EUR
 14 June 2023Monash University Australia Australian clinicians’ views, knowledge and experiences of long-acting injectable buprenorphine: How can care be optimised in the future? 99,983 EUR